Guru Ownership Trend
Guru Analysis for Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $808,039.75.
Top institutional holders include Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $495,024.58 net outflow during the quarter.
On the selling side, Cliff Asness reduced exposure by 2.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Maze Therapeutics, Inc. (MAZE)
Major holders include Cliff Asness ($810,485). According to the latest reported data, 1 tracked investment managers collectively hold approximately 27,161 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $495,024.58, with 0 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited MAZE. The total reported sell value was $495,024.58.
No tracked managers opened new positions or increased their holdings in MAZE during the most recent reporting period.